European consensus table 2006 on botulinum toxin for children with cerebral palsy

Eur J Paediatr Neurol. Sep-Nov 2006;10(5-6):215-25. doi: 10.1016/j.ejpn.2006.08.006. Epub 2006 Nov 13.


An interdisciplinary group of experienced botulinum toxin users and experts in the field of movement disorders was assembled, to develop a consensus on best practice for the treatment of cerebral palsy using a problem-orientated approach to integrate theories and methods. The authors tabulated the supporting evidence to produce a condensed but comprehensive information base, pooling data and experience from nine European countries, 13 institutions and more than 5500 patients. The consensus table summarises the current understanding regarding botulinum toxin treatment options in children with CP.

Publication types

  • Review

MeSH terms

  • Anti-Dyskinesia Agents / standards
  • Anti-Dyskinesia Agents / therapeutic use*
  • Botulinum Toxins / standards
  • Botulinum Toxins / therapeutic use*
  • Cerebral Palsy / drug therapy*
  • Child
  • Child, Preschool
  • Consensus*
  • Europe
  • Humans


  • Anti-Dyskinesia Agents
  • Botulinum Toxins